Abstract
Many drugs fall in the Biopharmaceutics Classification System category of class II and class IV drugs i.e. low solubility/high permeability and low solubility/low permeability respectively. Due to their hydrophobicity, there is difficulty in forming a stable formulation. Crystal engineering is implemented with a water-soluble molecule (called conformer) and an active pharmaceutical ingredient to improve the aqueous solubility. This review primarily is written to provide a general understanding of the experimental techniques used during the screening of cocrystals. It also discusses the challenges and future perspectives of cocrystal engineering and their importance to be thermodynamically stable to be acknowledged as a potentially marketable product.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
